IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $447,000 | -10.1% | 46,672 | +3.6% | 0.02% | -5.0% |
| Q2 2022 | $497,000 | -66.8% | 45,037 | -25.9% | 0.02% | -57.4% |
| Q3 2021 | $1,498,000 | +18.9% | 60,750 | +25.5% | 0.05% | +27.0% |
| Q2 2021 | $1,260,000 | +17.3% | 48,424 | +48.4% | 0.04% | -5.1% |
| Q3 2020 | $1,074,000 | +19.9% | 32,633 | 0.0% | 0.04% | +11.4% |
| Q2 2020 | $896,000 | -55.5% | 32,633 | -51.5% | 0.04% | -62.8% |
| Q1 2020 | $2,015,000 | +21.2% | 67,297 | +12.1% | 0.09% | +70.9% |
| Q4 2019 | $1,662,000 | +9.8% | 60,029 | -27.8% | 0.06% | +7.8% |
| Q3 2019 | $1,513,000 | -54.5% | 83,105 | -38.7% | 0.05% | -52.8% |
| Q2 2019 | $3,322,000 | – | 135,501 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |